Voya Investment Management LLC Trims Stock Position in AdaptHealth Corp. $AHCO

Voya Investment Management LLC decreased its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 10.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 27,667 shares of the company’s stock after selling 3,207 shares during the period. Voya Investment Management LLC’s holdings in AdaptHealth were worth $300,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the company. SummerHaven Investment Management LLC lifted its stake in shares of AdaptHealth by 1.7% during the first quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company’s stock valued at $866,000 after buying an additional 1,329 shares during the period. Oppenheimer Asset Management Inc. lifted its stake in shares of AdaptHealth by 6.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company’s stock valued at $356,000 after buying an additional 2,081 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of AdaptHealth by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 60,495 shares of the company’s stock valued at $656,000 after buying an additional 2,564 shares during the period. New York State Teachers Retirement System lifted its stake in shares of AdaptHealth by 3.3% during the first quarter. New York State Teachers Retirement System now owns 80,455 shares of the company’s stock valued at $872,000 after buying an additional 2,600 shares during the period. Finally, Humankind Investments LLC lifted its stake in shares of AdaptHealth by 15.5% during the first quarter. Humankind Investments LLC now owns 20,770 shares of the company’s stock valued at $225,000 after buying an additional 2,791 shares during the period. Hedge funds and other institutional investors own 82.67% of the company’s stock.

Insider Activity

In other news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total value of $79,786.00. Following the completion of the sale, the director owned 50,045 shares of the company’s stock, valued at $486,937.85. This represents a 14.08% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.55% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on AHCO shares. Zacks Research downgraded shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Wall Street Zen raised shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Five equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $13.40.

AdaptHealth Price Performance

AdaptHealth stock opened at $8.89 on Monday. AdaptHealth Corp. has a 52-week low of $7.11 and a 52-week high of $11.63. The firm has a fifty day moving average of $9.28 and a 200-day moving average of $9.14. The firm has a market capitalization of $1.20 billion, a P/E ratio of 16.46, a PEG ratio of 0.99 and a beta of 1.59. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.14.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.